Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

31,600 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Glyoxalase System as a Therapeutic Target against Diabetic Retinopathy.
Aragonès G, Rowan S, G Francisco S, Yang W, Weinberg J, Taylor A, Bejarano E. Aragonès G, et al. Among authors: yang w. Antioxidants (Basel). 2020 Oct 30;9(11):1062. doi: 10.3390/antiox9111062. Antioxidants (Basel). 2020. PMID: 33143048 Free PMC article. Review.
Autophagic receptor p62 protects against glycation-derived toxicity and enhances viability.
Aragonès G, Dasuri K, Olukorede O, Francisco SG, Renneburg C, Kumsta C, Hansen M, Kageyama S, Komatsu M, Rowan S, Volkin J, Workman M, Yang W, Daza P, Ruano D, Dominguez-Martín H, Rodríguez-Navarro JA, Du XL, Brownlee MA, Bejarano E, Taylor A. Aragonès G, et al. Among authors: yang w. Aging Cell. 2020 Nov;19(11):e13257. doi: 10.1111/acel.13257. Epub 2020 Nov 4. Aging Cell. 2020. PMID: 33146912 Free PMC article.
Design of High Affinity Binders to Convex Protein Target Sites.
Baker D, Yang W, Hicks DR, Ghosh A, Schwartze TA, Coventry B, Goreshnik I, Allen A, Halabiya S, Kim C, Hinck CS, Lee DS, Bera A, Li Z, Wang Y, Schlichthaerle T, Cao L, Huang B, Garrett S, Gerben SR, Rettie S, Heine P, Edman N, Murray AN, Carter LP, Stewart L, Almo S, Hinck AP. Baker D, et al. Among authors: yang w. bioRxiv [Preprint]. 2024 May 2:2024.05.01.592114. doi: 10.1101/2024.05.01.592114. bioRxiv. 2024. PMID: 38746206 Free PMC article. Preprint.
Immune checkpoint inhibitors and anti-vascular endothelial growth factor antibody/tyrosine kinase inhibitors with or without transarterial chemoembolization as first-line treatment for advanced hepatocellular carcinoma (CHANCE2201): a target trial emulation study.
Jin ZC, Chen JJ, Zhu XL, Duan XH, Xin YJ, Zhong BY, Chen JZ, Tie J, Zhu KS, Zhang L, Huang M, Piao MJ, Li X, Shi HB, Liu RB, Xu AB, Ji F, Wu JB, Shao GL, Li HL, Huang MS, Peng ZY, Ji JS, Yuan CW, Liu XF, Hu ZC, Yang WZ, Yin GW, Huang JH, Ge NJ, Qi X, Zhao Y, Zhou JW, Xu GH, Tu Q, Lin HL, Zhang YJ, Jiang H, Shao HB, Su YJ, Chen TS, Shi BQ, Zhou X, Zhao HT, Zhu HD, Ren ZG, Teng GJ; CHANCE2201 Investigators. Jin ZC, et al. Among authors: yang wz. EClinicalMedicine. 2024 May 6;72:102622. doi: 10.1016/j.eclinm.2024.102622. eCollection 2024 Jun. EClinicalMedicine. 2024. PMID: 38745965 Free PMC article.
31,600 results
You have reached the last available page of results. Please see the User Guide for more information.